ARCH Venture Partners XII
Major shareholder at City Therapeutics · 8 reported transactions in 4 companies · latest trade Oct 19, 2026
Their record
Across their whole record, 2 purchases can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move +9.7%, S&P 500 +10.9% over the same days.
Their trades
Bought | Oct 19, 2026 | Oct 19, 2026 close $21.46 → Oct 29, 2026 close $22.14. S&P 500 +0.4% over the same days. | ||
Bought | Oct 27, 2025 | Oct 27, 2025 close $2.69 → Oct 23, 2026 close $0.38. S&P 500 +10.9% over the same days. | ||
Bought | Aug 1, 2025 | Aug 1, 2025 close $4.04 → Oct 27, 2026 close $4.35. S&P 500 +23.8% over the same days. |
BoughtCity Therapeutics
$3.06M
Oct 19, 2026 close $21.46 → Oct 29, 2026 close $22.14. S&P 500 +0.4% over the same days.
BoughtNeumora Therapeutics
$5M
Oct 27, 2025 close $2.69 → Oct 23, 2026 close $0.38. S&P 500 +10.9% over the same days.
BoughtPrime Medicine
$10M
Aug 1, 2025 close $4.04 → Oct 27, 2026 close $4.35. S&P 500 +23.8% over the same days.